A Multiple Myeloma Trial in Patients With Bone Metastases

Summary

The purpose of this trial is to study the safety of treating patients with multiple myeloma and at least one bone lesion with zoledronic acid 4mg intravenously (IV) every 3 - 4 weeks for 2 years. Patients will receive a zoledronic acid infusion for 15 minutes or 30 minutes.

Timeline

Start

2004-10

Primary completion

2007-10

Completion

2007-10

Drugs

Indications